Jabra Enhance Plus vs Signia Pure C&G IX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Jabra Enhance Plus
The Jabra Enhance Plus is a mid-priced OTC hearing aid ($799) that earns a B grade with a SoundScore of 3.8/5 in our lab testing, ranking #28 of 65 devices in the OTC category. This visible-in-ear device delivers strong speech-in-quiet performance, scoring 4.2/5—a full 1.36 points above the category average. Music streaming is another highlight at 3.8/5, nearly 1.9 points above average, making it a solid choice for users who value audio quality beyond speech. Speech-in-noise performance scores 2.1/5, which is above the category average by 0.62 points but remains mixed in absolute terms for challenging listening environments. The most significant limitation is own-voice comfort, scoring just 0.3/5—well below the category average of 2.51/5. Users sensitive to how their own voice sounds while wearing hearing aids should consider this trade-off carefully. Feedback handling is excellent at 4.7/5, meaning wearers can expect stable performance without whistling or squealing. The Jabra Enhance Plus is best suited for users who prioritize clear speech in quieter settings and enjoy streaming music or calls to their iPhone. Those frequently in noisy environments or particularly bothered by occlusion effects may want to explore alternatives. Several competitors in the same price range achieve higher overall scores, including the Sony CRE-E10 and Lexie B2 Plus.
Choice

Signia Pure C&G IX
The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit